MARKET

AGRX

AGRX

Agile
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.485
-0.015
-1.00%
Opening 13:05 06/17 EDT
OPEN
1.490
PREV CLOSE
1.500
HIGH
1.501
LOW
1.470
VOLUME
209.47K
TURNOVER
--
52 WEEK HIGH
3.890
52 WEEK LOW
1.280
MARKET CAP
131.07M
P/E (TTM)
-2.1251
1D
5D
1M
3M
1Y
5Y
Bionano Genomics to join Russel 3000 Index, while AcelRx Pharmaceuticals to see deletion among healthcare stocks
At the conclusion of the 2021 Russell indexes annual reconstitution following notable healthcare stocks will join the Russell 3000 Index, effective June 28 after the U.S. market opens.Bionano Genomics (BNGO), Asensus Surgical (ASXC), Ocugen
Seekingalpha · 2d ago
BB, MARA, SOS and CAN among premarket gainers
Vertex Energy (VTNR) +98% on deal for Shell's Mobile refinery.Moxian (MOXC) +37%.1847 Goedeker (GOED) +22%.SOS Limited (SOS) +14%.Bit Digital (BTBT) +13%.Vir Biotechnology (VIR) +9% as GSK/Vir COVID-19 biologic wins FDA Emergency Use
Seekingalpha · 05/27 12:25
Agile Therapeutics to Participate in the William Blair 41st Annual Growth Stock Conference
Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced the company will be participating virtually in the William Blair 41 Annual Growth Stock Conference.
GlobeNewswire · 05/26 12:09
12 Health Care Stocks Moving In Monday's Pre-Market Session
 
Benzinga · 05/17 12:13
The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11)
Benzinga · 05/12 12:57
Agile Therapeutics to Participate in Virtual Fireside Chat as Part of the 2021 RBC Capital Markets Global Healthcare Conference
Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that Al Altomari, Chairman and Chief Executive Officer, will participate in a virtual fireside chat as part of the 2021 RBC Capital Markets Global Healthcare Conference ...
GlobeNewswire · 05/12 12:00
The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 10)
Benzinga · 05/11 11:54
Stocks That Hit 52-Week Lows On Monday
  Monday morning saw 78 companies set new 52-week lows.
Benzinga · 05/10 14:41
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of AGRX. Analyze the recent business situations of Agile through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average AGRX stock price target is 6.25 with a high estimate of 7.00 and a low estimate of 6.00.
EPS
Institutional Holdings
Institutions: 113
Institutional Holdings: 47.24M
% Owned: 53.52%
Shares Outstanding: 88.26M
TypeInstitutionsShares
Increased
19
797.38K
New
13
725.84K
Decreased
26
1.03M
Sold Out
16
2.69M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
-0.59%
Pharmaceuticals & Medical Research
-0.35%
Key Executives
Chairman/Chief Executive Officer/Director
Alfred Altomari
Chief Financial Officer/Senior Vice President
Dennis Reilly
Senior Vice President/General Counsel/Secretary
Geoffrey Gilmore
Senior Vice President
Robert Conway
Senior Vice President
Paul Korner
Lead Director/Independent Director
Seth Fischer
Independent Director
Sharon Barbari
Independent Director
Sandra Carson
Independent Director
John Hubbard
Independent Director
Ajit Shetty
Independent Director
James Tursi
No Data
About AGRX
Agile Therapeutics, Inc. is a women's health specialty pharmaceutical company. The Company is focused in the development and commercialization of prescription contraceptive products. The Company has developed a transdermal patch technology, called Skinfusion. The Company's lead product candidate is Twirla, also known as AG200-15, is a combined hormonal contraceptive (CHC) patch. In addition to Twirla, the Company is developing a pipeline of other new transdermal contraceptive products, including AG200-ER, which is a regimen designed to allow a woman to extend the length of her cycle; AG200-SP, which is a regimen designed to provide a shortened hormone-free interval, and AG890, which is a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. Each of its product candidates utilizes its Skinfusion technology designed to deliver contraceptive-levels of hormones to the blood stream through the skin over a seven-day period.

Webull offers kinds of Agile Therapeutics Inc stock information, including NASDAQ:AGRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AGRX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AGRX stock methods without spending real money on the virtual paper trading platform.